Patents by Inventor Lennart Lundberg

Lennart Lundberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220267469
    Abstract: The present invention relates to novel isolated antibodies and antigen-binding fragments thereof that bind to human Bile Salt-Stimulated Lipase (hBSSL). The antibodies and antigen-binding fragments thereof bind to a previously uncharacterized epitope, situated in the N-terminal part of hBSSL and identified as comprising the amino acid residues 7-12 and the amino acid residues 42-55. The 5 present invention also relates to the medical uses of the antibodies and/or the antigen-binding fragments thereof, in particular in treatment of inflammatory conditions, and to related pharmaceutical compositions.
    Type: Application
    Filed: July 10, 2020
    Publication date: August 25, 2022
    Inventors: Olle HERNELL, Susanne LINDQUIST, Lennart LUNDBERG, Helena PERSSON LOTSHOLM
  • Publication number: 20120190751
    Abstract: The present invention relates to the use of benzylideneaminoguanidines for the treatment of inflammation and pain. In one preferred embodiment, the invention relates to the use of N-(2-chloro-3,4-dimethoxybenzylideneamino)guanidine for the treatment of rheumatoid arthritis.
    Type: Application
    Filed: July 30, 2010
    Publication date: July 26, 2012
    Applicant: ANA-MAR AB
    Inventors: Niklas Palmqvist, Anders Sjödin, Christina Wenglén, Christofer Flood, Lennart Lundberg, Elisabeth Seifert, Per Lek, Arne Boman
  • Patent number: 6525241
    Abstract: The present invention relates to human bile salt-stimulated lipase (BSSL) obtainable from transgenic sheep. The invention further relates to transgenic sheep whose germ cells and somatic cells contain a recombinant nucleotide molecule comprising a nucleotide sequence encoding for human BSSL. The invention also relates to methods for producing said transgenic animals, as well as to methods for producing human BSSL derived from transgenic animals. In addition, the invention provides the use of compositions comprising BSSL in the treatment of diseases relating to exocrine pancreatic insufficiency, and for improvement of the utilization of dietary lipids in preterm born infants.
    Type: Grant
    Filed: July 18, 1999
    Date of Patent: February 25, 2003
    Assignee: AstraZeneca AB
    Inventors: Michael Dalrymple, Lennart Lundberg, Mats Strömqvist
  • Patent number: 4280284
    Abstract: Closed water and steam conditioning system for peeler logs in which steam from the boiler house is supplied to an evaporator and clean condensate returned to the boiler. Steam from the evaporator is directed to conditioning tunnels for the peeler logs. Dirty condensate from the conditioning tunnels is delivered to a sump area in which the dirty condensate is screened and at least part of which is directed to shower heads in the conditioning tunnels. The remaining dirty condensate is then directed to the evaporator where steam is generated therefrom. Caustic soda is added to the acidic dirty condensate to maintain a basic pH.
    Type: Grant
    Filed: May 5, 1980
    Date of Patent: July 28, 1981
    Assignee: A. H. Lundberg Associates, Inc.
    Inventors: Elmer F. Guthrie, Lennart A. Lundberg
  • Patent number: D465823
    Type: Grant
    Filed: March 3, 2000
    Date of Patent: November 19, 2002
    Inventor: Lennart Lundberg